Prudhomme Thomas, Peri Lluis, Pecoraro Alessio, Territo Angelo, Etcheverry Begoña, Ortved Milla, Røder Andreas, Mirza Idu, Vignolini Graziano, Rohrsted Malene, López de Mesa Rodriguez Byron, Mercier Jeremy, Doumerc Nicolas, Masieri Lorenzo, Vigues Francesc, Breda Alberto, Serni Sergio, Alcaraz Antonio, Musquera Mireia, Campi Riccardo
Department of Urology, Hospital Clinic, Barcelona, Spain.
Department of Urology, Rangueil University Hospital, Toulouse, France.
Eur Urol Open Sci. 2025 Aug 6;79:32-41. doi: 10.1016/j.euros.2025.06.013. eCollection 2025 Sep.
In the context of deceased donors (DDs), robotic-assisted kidney transplantation (RAKT) is underutilized due to specific logistical and technical challenges. The aim of this study was to report the outcomes of DD-RAKT performed in centers involved in the European Association of Urology Robotic Urology Section (ERUS)-RAKT working group.
This retrospective analysis is based on a prospectively collected multicenter database including data on DD-RAKT performed at seven referral ERUS-RAKT European centers from July 2015 to April 2024. Intraoperative, perioperative, and midterm functional outcomes after DD-RAKT were assessed. The decision-making strategy regarding the selection of a robotic versus an open surgical approach for kidney transplantation was also reported across the included centers.
A total of 67 patients with a median age of 36 yr (interquartile range [IQR]: 24-58) underwent DD-RAKT. Most donors were donors after brain death (80.6%), followed by donors after uncontrolled circulatory death (10.4%); there were 26 "expanded criteria" donors (39%). The median cold ischemia time was 14.8 h (IQR: 11.0-19.0). Eight patients (11.9%) had orthotopic DD-RAKT, while 59 patients (88.1%) had heterotopic DD-RAKT. The median operative time and the median rewarming time were 220 min (IQR: 180.0-252.0) and 50 min (IQR: 42-60), respectively. The major postoperative surgical complications (Clavien-Dindo ≥3) occurred in 11 patients (16%). Eighteen patients (27%) experienced delayed graft function. At a median follow-up of 27.1 mo (IQR: 9.5-59.4), graft survival rate was 92.6% and patient survival rate was 97.0%. The last median estimated glomerular filtration rate was 55.0 ml/min/1.73 m (IQR: 41.5-70.0). The main study limitations are its retrospective nature and the lack of a comparator group.
DD-RAKT is feasible and safe at experienced centers, providing a viable way of expanding transplantation access to patients with end-stage kidney disease. Notwithstanding the logistical barriers for DD-RAKT, careful recipient selection and organ matching are key factors to achieve the best perioperative and functional outcomes.
Robotic kidney transplantation using grafts from deceased donors is technically feasible and safe in well-selected recipients at experienced referral centers, showing favorable intra- and postoperative outcomes. While robotic kidney transplantation from deceased donors may be challenging to implement in clinical practice due to organizational and logistical barriers (which may vary across hospitals and countries), careful recipient selection is essential to ensure the best perioperative and functional outcomes.
在已故供体(DDs)的背景下,由于特定的后勤和技术挑战,机器人辅助肾移植(RAKT)的应用未得到充分利用。本研究的目的是报告在欧洲泌尿外科学会机器人泌尿外科分会(ERUS)-RAKT工作组参与的中心进行的DD-RAKT的结果。
本回顾性分析基于一个前瞻性收集的多中心数据库,该数据库包含2015年7月至2024年4月在七个ERUS-RAKT欧洲转诊中心进行的DD-RAKT的数据。评估了DD-RAKT术后的术中、围手术期和中期功能结果。还报告了各纳入中心在选择机器人手术与开放手术进行肾移植方面的决策策略。
共有67例患者接受了DD-RAKT,中位年龄为36岁(四分位间距[IQR]:24 - 58岁)。大多数供体为脑死亡后供体(80.6%),其次是未控制循环死亡后供体(10.4%);有26例“扩大标准”供体(39%)。中位冷缺血时间为14.8小时(IQR:11.0 - 19.0)。8例患者(11.9%)接受了原位DD-RAKT,而59例患者(88.1%)接受了异位DD-RAKT。中位手术时间和中位复温时间分别为220分钟(IQR:180.0 - 252.0)和50分钟(IQR:42 - 60)。主要术后手术并发症(Clavien-Dindo≥3级)发生在11例患者(16%)中。18例患者(27%)出现移植肾功能延迟。中位随访27.1个月(IQR:9.5 - 59.4)时,移植肾存活率为92.6%,患者存活率为97.0%。最后一次中位估计肾小球滤过率为55.0 ml/min/1.73m²(IQR:41.5 - 70.0)。主要研究局限性在于其回顾性性质以及缺乏对照组。
在经验丰富的中心,DD-RAKT是可行且安全的,为扩大终末期肾病患者的移植途径提供了一种可行的方法。尽管DD-RAKT存在后勤障碍,但仔细选择受者和器官匹配是实现最佳围手术期和功能结果的关键因素。
在经验丰富的转诊中心,对精心挑选的受者使用已故供体的移植物进行机器人肾移植在技术上是可行且安全的,显示出良好的术中和术后结果。虽然由于组织和后勤障碍(可能因医院和国家而异),已故供体的机器人肾移植在临床实践中实施可能具有挑战性,但仔细选择受者对于确保最佳围手术期和功能结果至关重要。